Prognostic factors in 194 patients with chronic necrotizing pulmonary aspergillosis

Internal Medicine

Volumn 52, Issue 7, 2013, Pages 727-734

  Nakamoto, Keitaro ^a   Takayanagi, Noboru ^a   Kanauchi, Tetsu ^a   Ishiguro, Takashi ^a   Yanagisawa, Tsutomu ^a   Sugita, Yutaka ^a  

^a Saitama Cardiovascular and Respiratory Center   (Japan)

Author keywords

Aspergillus; Chronic pulmonary aspergillosis; Mortality; Prognosis; Treatment

Indexed keywords

AMPHOTERICIN B; AMPHOTERICIN B LIPID COMPLEX; ITRACONAZOLE; MICAFUNGIN; PREDNISOLONE; VORICONAZOLE;

AGED; ALLERGIC PNEUMONITIS; ANEMIA; ARTICLE; COMORBIDITY; DISEASE COURSE; FEMALE; FOLLOW UP; HEMOPTYSIS; HUMAN; HYPOALBUMINEMIA; INTERSTITIAL PNEUMONIA; LUNG ASPERGILLOSIS; LUNG TUBERCULOSIS; MAJOR CLINICAL STUDY; MALE; MORTALITY; PROGNOSIS; RETROSPECTIVE STUDY; SIDE EFFECT;

ADULT; AGED; AGED, 80 AND OVER; C-REACTIVE PROTEIN; COHORT STUDIES; FEMALE; FOLLOW-UP STUDIES; HUMANS; INVASIVE PULMONARY ASPERGILLOSIS; MALE; MIDDLE AGED; PROGNOSIS; RETROSPECTIVE STUDIES;

EID: 84875890385     PISSN: 09182918     EISSN: 13497235     Source Type: Journal    
DOI: 10.2169/internalmedicine.52.9142     Document Type: Article

References (30)

1. Belcher JR, Plummer NS. Surgery in broncho-pulmonary aspergillosis. Br J Dis Chest 54: 335-341, 1960.
2. Gefter WB, Weingrad TR, Epstein DM, Ochs RH, Miller WT. "Semi-invasive" pulmonary aspergillosis: a new look at the spectrum of aspergillus infections of the lung. Radiology 140: 313-321, 1981.
3. Binder RE, Faling LJ, Pugatch RD, Mahasaen C, Snider GL. Chronic necrotizing pulmonary aspergillosis: a discrete clinical entity. Medicine (Baltimore) 61: 109-124, 1982.
4. Denning DW, Riniotis K, Dobrashian R, Sambatakou H. Chronic cavitary and fibrosing pulmonary and pleural aspergillosis: case series, proposed nomenclature change, and review. Clin Infect Dis 37 (Suppl 3): S265-S280, 2003.
5. Limper AH, Knox KS, Sarosi GA, et al. An official American Thoracic Society statement: treatment of fungal infections in adult pulmonary and critical care patients. Am J Respir Crit Care Med 183: 96-128, 2011.
6. Kousha M, Tadi R, Soubani AO. Pulmonary aspergillosis: a clinical review. Eur Respir Rev 20: 156-174, 2011.
7. Saraceno JL, Phelps DT, Ferro TJ, Futerfas R, Schwartz DB. Chronic necrotizing pulmonary aspergillosis: approach to management. Chest 112: 541-548, 1997.
8. Caras WE, Pluss JL. Chronic necrotizing pulmonary aspergillosis: pathologic outcome after itraconazole therapy. Mayo Clin Proc 71: 25-30, 1996.
9. Dupont B. Itraconazole therapy in aspergillosis: study in 49 patients. J Am Acad Dermatol 23: 607-614, 1990.
10. De Beule K, De Doncker P, Cauwenbergh G, et al. The treatment of aspergillosis and aspergilloma with itraconazole, clinical results of an open international study (1982-1987). Mycoses 31: 476-485, 1988.
11. Camuset J, Nunes H, Dombret MC, et al. Treatment of chronic pulmonary aspergillosis by voriconazole in nonimmunocompromised patients. Chest 131: 1435-1441, 2007.
12. Nam HS, Jeon K, Um SW, et al. Clinical characteristics and treatment outcomes of chronic necrotizing pulmonary aspergillosis: a review of 43 cases. Int J Infect Dis 14: e479-e482, 2010.
13. Hagiwara E, Sekine A, Sato T, et al. Clinical features of chronic necrotizing pulmonary aspergillosis treated with voriconazole in patients with chronic respiratory disease. Nihon Kokyuki Gakkai Zasshi 46: 864-869, 2008 (in Japanese, Abstract in English).
14. Ohba H, Miwa S, Shirai M, et al. Clinical characteristics and prognosis of chronic pulmonary aspergillosis. Respir Med 106: 724-729, 2012.
15. Nakamoto K, Takayanagi N, Kurita Y, et al. Clinical features and long-term prognosis of chronic pulmonary aspergillosis [abstract]. Annals of the Japanese Respiratory Society 1: S311, 2012 (in Japanese).
16. Kohno S, Masaoka T, Yamaguchi H, et al. A multicenter, openlabel clinical study of micafungin (FK463) in the treatment of deep-seated mycosis in Japan. Scand J Infect Dis 36: 372-379, 2004.
17. Kobashi Y, Fukuda M, Yoshida K, Miyashita N, Niki Y, Oka M. Chronic necrotizing pulmonary aspergillosis as a complication of pulmonary Mycobacterium avium complex disease. Respirology 11: 809-813, 2006.
18. Hope WW, Walsh TJ, Denning DW. The invasive and saprophytic syndromes due to Aspergillus spp. Med Mycol 43 (Suppl 1): S 207-S238, 2005.
19. Smith NL, Denning DW. Underlying conditions in chronic pulmonary aspergillosis including simple aspergilloma. Eur Respir J 37: 865-872, 2011.
20. Franquet T, Müller NL, Giménez A, Domingo P, Plaza V, Bordes R. Semiinvasive pulmonary aspergillosis in chronic obstructive pulmonary disease: radiologic and pathologic findings in nine patients. AJR Am J Roentgenol 174: 51-56, 2000.
21. Kim SY, Lee KS, Han J, et al. Semiinvasive pulmonary aspergillosis: CT and pathologic findings in six patients. AJR Am J Roentgenol 174: 795-798, 2000.
22. Kappe R, Schulze-Berge A, Sonntag HG. Evaluation of eight antibody tests and one antigen test for the diagnosis of invasive aspergillosis. Mycoses 39: 13-23, 1996.
23. Walter JE, Jones RD. Serologic tests in diagnosis of aspergillosis. Dis Chest 53: 729-735, 1986.
24. Kohno S, Izumikawa K, Ogawa K, et al. Intravenous micafungin versus voriconazole for chronic pulmonary aspergillosis: a multicenter trial in Japan. J Infect 61: 410-418, 2010.
25. Jain LR, Denning DW. The efficacy and tolerability of voriconazole in the treatment of chronic cavitary pulmonary aspergillosis. J Infect 52: e133-e137, 2006.
26. Sambatakou H, Dupont B, Lode H, Denning DW. Voriconazole treatment for subacute invasive and chronic pulmonary aspergillosis. Am J Med 119: e17-e24, 2006.
27. Tomioka H, Kaneda T, Kida Y, et al. An open, noncomparative multicenter study of the efficacy and safety of itraconazole injections and high dose capsules in chronic pulmonary aspergillosis. Kansenshogaku Zasshi 85: 644-651, 2011 (in Japanese, Abstract in English).
28. Yoshida K, Kurashima A, Kamei K, et al. Efficacy and safety of short-and long-term treatment of itraconazole on chronic necrotizing pulmonary aspergillosis in multicenter study. J Infect Chemother 18: 378-385, 2012.
29. Cadranel J, Philippe B, Hennequin C, et al. Voriconazole for chronic pulmonary aspergillosis: a prospective multicenter trial. Eur J Clin Microbiol Infect Dis 31: 3231-3239, 2012.
30. Denning DW. Chronic forms of pulmonary aspergillosis. Clin Microbiol Infect 7 (Suppl 2): 25-31, 2001.